Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis

End‐stage liver fibrosis frequently progresses to portal vein thrombosis, formation of oesophageal varices, hepatic encephalopathy, ascites, hepatocellular carcinoma and liver failure. Mesenchymal stem cells (MSCs), when transplanted in vivo, migrate into fibrogenic livers and then differentiate int...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of cellular and molecular medicine Ročník 23; číslo 3; s. 1657 - 1670
Hlavní autoři:	Hu, Chenxia, Zhao, Lingfei, Duan, Jinfeng, Li, Lanjuan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England John Wiley & Sons, Inc 01.03.2019 John Wiley and Sons Inc
Témata:	Animals Ascites Bile Cell Differentiation Cytokines Esophagus Fibrosis Growth factors Hepatic encephalopathy Hepatocellular carcinoma Hepatocytes Humans improvement Inflammation Liver Liver cancer Liver Cirrhosis - pathology Liver Cirrhosis - therapy Liver diseases Liver failure liver fibrosis Liver Regeneration mechanism mesenchymal stem cell Mesenchymal Stem Cell Transplantation - methods Mesenchymal Stem Cells - cytology Mesenchyme Portal vein Quality of life regression Review Reviews Stem cell transplantation Thrombosis mesenchymal stem cell liver fibrosis improvement mechanism regression
ISSN:	1582-1838, 1582-4934, 1582-4934
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!